Literature DB >> 25805835

India should screen all tuberculosis patients for drug resistant disease at diagnosis.

Yogesh Jain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25805835     DOI： 10.1136/bmj.h1235

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  The End TB Strategy : India can blaze the trail.

Authors:  Madhukar Pai
Journal:  Indian J Med Res       Date:  2015-03       Impact factor: 2.375

2.  Tuberculosis therapy in Mumbai: Critical importance of drug-susceptibility testing.

Authors:  Amrita Daftary; Madhukar Pai
Journal:  Lung India       Date:  2016 May-Jun

3.  High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.

Authors:  Hemant Deepak Shewade; Arun M Kokane; Akash Ranjan Singh; Manoj Verma; Malik Parmar; Ashish Chauhan; Sanjay Singh Chahar; Manoj Tiwari; Sheeba Naz Khan; Vivek Gupta; Jaya Prasad Tripathy; Mukesh Nagar; Sanjai Kumar Singh; Pradeep Kumar Mehra; Ajay Mv Kumar
Journal:  BMC Health Serv Res       Date:  2017-04-04       Impact factor: 2.655

4.  Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: An operational research from Chennai, India.

Authors:  Hemant Deepak Shewade; Dina Nair; Joel S Klinton; Malik Parmar; J Lavanya; Lakshmi Murali; Vivek Gupta; Jaya Prasad Tripathy; Soumya Swaminathan; Ajay M V Kumar
Journal:  J Epidemiol Glob Health       Date:  2017-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.